IRCT20120918010876N4 2018.
Study name | |
Methods | Design: RCT Setting: Mahdieh hospital, Tehran, Iran |
Participants | Inclusion criteria: women with singleton pregnancy with elective cesarean section at week 37 to 38 weeks and 6 days will enrol in the study Exclusion criteria: multiple pregnancies, fetus with major congenital anomalies, fetus with other medical or midwifery conditions that give birth earlier, receive dexamethasone or betamethasone during pregnancy, maternal severe hypertension, maternal history of peptic ulcer, and evidences of intrauterine infection Target sample size: 220 |
Interventions | Treatment group: intramuscular injection of 12 mg betamethasone in two doses between 24 hours, 48 hours before cesarean section Control group: cesarean section without betamethasone injection |
Outcomes | Neonatal respiratory outcomes
|
Starting date | |
Contact information | |
Notes | Study dates: registered 11 January 2018 Funding sources: "Shahid Beheshti University of Medical Sciences" Declarations of interest: not reported We contacted the investigators on 8 March 2020 to ask if they had any outcome data we could include. Contact details: z.joshaghani@hotmail.com |